Literature DB >> 33685600

CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing.

Munshi Azad Hossain1.   

Abstract

Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas system has been discovered as an adaptive-immune system in prokaryotes. Microbes like bacteria and archaea use CRISPR-Cas9 as a part of their defense mechanism to ward off the virus and cleave their DNA. Over the past decades, researchers have identified that this simple CRISPR-Cas9 system of bacteria can be utilized to cut any DNA. It is also possible to make precise editing in the genome of almost any organism. This discovery has revolutionized the CRISPR-Cas9 tools and made it one of the most precise gene editing technology known till date. The simple, versatile and programmable nature of CRISPR-Cas9 system 5wthat contains a single guide RNA and Cas9 enzyme, made it an attractive choice for genome editing application. Scientists in the field of molecular biology, genetics and medicine extensively use this transformative technology to study gene regulation and also for treatment of several incurable genetic diseases. Today, CRISPR-Cas9 is the most powerful breakthrough of the century for its immense potential to modulate gene expression in living cells and its application to medicine and human health. Recently, ethical challenges associated with the application of this technology to human health become a hot debate in the scientific community. In this chapter the brief history of development of CRISPR-Cas9 tools and its immense application potential have been discussed.
© 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial defense system; CRISPR; CRISPR baby; Cas9; Genome editing

Year:  2021        PMID: 33685600     DOI: 10.1016/bs.pmbts.2021.01.001

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  3 in total

Review 1.  CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.

Authors:  Ujjayani Saha; Rashmi Gondi; Amrita Patil; Sunil D Saroj
Journal:  Mol Biotechnol       Date:  2022-08-08       Impact factor: 2.860

2.  Reverting TP53 Mutation in Breast Cancer Cells: Prime Editing Workflow and Technical Considerations.

Authors:  Asmaa Y Abuhamad; Nurul Nadia Mohamad Zamberi; Ling Sheen; Safaa M Naes; Siti Nur Hasanah Mohd Yusuf; Asilah Ahmad Tajudin; M Aiman Mohtar; Amir Syahir Amir Hamzah; Saiful Effendi Syafruddin
Journal:  Cells       Date:  2022-05-11       Impact factor: 7.666

3.  Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.

Authors:  Olga Semikolenova; Lubov Sakovina; Elizaveta Akhmetova; Daria Kim; Ivan Vokhtantsev; Victor Golyshev; Mariya Vorobyeva; Sergey Novopashin; Darya Novopashina
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.